Novel Perspective on Alzheimer’s Disease Treatment: Rosmarinic Acid Molecular Interplay with Copper(II) and Amyloid β
Open Access
- 20 July 2020
- Vol. 10 (7), 118
- https://doi.org/10.3390/life10070118
Abstract
Alzheimer’s disease is a severe disorder that affects millions of people worldwide. It is a very debilitating disease with no cure at the moment. The necessity of finding an effective treatment is very demanding, and the entire scientific community is putting in a lot of effort to address this issue. The major hallmark of Alzheimer’s disease is the presence of toxic aggregated species in the brain, impaired metal homeostasis, and high levels of oxidative stress. Rosmarinic acid is a well-known potent antioxidant molecule, the efficacy of which has been proved both in vitro and in vivo. In this study, we investigated the possible role played by rosmarinic acid as a mediator of the copper(II)-induced neurotoxicity. Several spectroscopic techniques and biological assays were applied to characterize the metal complexes and to evaluate the cytotoxicity and the mutagenicity of rosmarinic acid and its Cu(II) complex. Our data indicate that rosmarinic acid is able to interfere with the interaction between amyloid β and Cu(II) by forming an original ternary association.Keywords
Funding Information
- Narodowe Centrum Nauki (UMO-2017/26/A/ST5/00363)
This publication has 80 references indexed in Scilit:
- Natural Compounds against Alzheimer’s Disease: Molecular Recognition of Aβ1–42 Peptide by Salvia sclareoides Extract and its Major Component, Rosmarinic Acid, as Investigated by NMRChemistry – An Asian Journal, 2013
- Phenolic Compounds Prevent Amyloid β-Protein Oligomerization and Synaptic Dysfunction by Site-specific Binding*Online Journal of Public Health Informatics, 2012
- The Heterogeneous Nature of Cu2+Interactions with Alzheimer’s Amyloid-β PeptideAccounts of Chemical Research, 2011
- The role of His-50 of α-synuclein in binding Cu(ii): pH dependence, speciation, thermodynamics and structureMetallomics, 2011
- Nutraceutical Antioxidants as Novel Neuroprotective AgentsMolecules, 2010
- Copper binding to chicken and human prion protein amylodogenic regions: Differences and similarities revealed by Ni2+ as a diamagnetic probeJournal of Inorganic Biochemistry, 2010
- Phenolic Compounds Prevent Alzheimer’s Pathology through Different Effects on the Amyloid-β Aggregation PathwayThe American Journal of Pathology, 2009
- The role of tau phosphorylation and cleavage in neuronal cell deathFrontiers in Bioscience-Landmark, 2007
- Structural and thermodynamical properties of CuII amyloid-β16/28 complexes associated with Alzheimer’s diseaseJBIC Journal of Biological Inorganic Chemistry, 2006
- Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)Chemical Reviews, 2006